model for India. We want
to now start introducing
our other products such as
spinal implants,
orthopedic products.
Again, we will like to go
into the very niche areas
such as tumors, bone
tumors, extremely
complex re-revision
surgeries of the hip etc.
Those are the niche areas
where the value
proposition and product
differentiation is very
high. Instead of using the
standard implant, we will
custom make the implant
so that you don’t have to
do the re-revision surgery.
So, in this way, our
products are quite unique
and innovative.
“
Anatomics
manufactures patient
specific cranial,
facial, chest wall and
other skeletal and
soft tissue implants
and surgical tools for
reconstructive
surgeons in Australia
and around the
world.”
plan to do in the next nine
months is to establish the
key clinical partnerships
with surgeons across
So, does that mean
states. These surgeons
you will also market must be innovators who
stents in India? What value the importance of
are your India plans? the 3D printed implants
and results it could bring
We won’t be doing stents
to patients. We will also
but we will introduce
look at creating new
implants such as hip,
business models in India
shoulder, and other parts
as the products that are
which are not very well
highly priced in western
served as of now. What we
nations might not work
here. We will try to work
on a well suitable product
line that maintains the
quality yet is affordable in
India.
As of now we haven’t come
up with a India specific
business strategy but we
are working on it. We see
the enormous potential in
India due to the unmet
needs of huge number of
people here. Opportunities
are there but there are
challenges such as
regulatory and market
access. The way system
works, how clinicians
work, surgeons and supply
chain are all factors.
Pricing being one of the
issue as the products
offered by us are
expensive. We are looking
for building partnerships
including distributors and
manufacturing companies.
Partnerships with the
hospitals, clinicians and
surgeons are also on cards.
How aware is the
market in India
www.BioVoiceNews.com
21